Information about successful completion of Inspection of JSTL Clinical and Bioanalytical facilities by CDSCO (Central Drugs Standard Control Organisation) under Regulation 30 of SEBI(LODR) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Microcap 250 and 2.0 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CDSCO inspected Jeevan Scientific Technology's clinical facility at Balanagar and bioanalytical facility at Manikonda, Hyderabad, between April 1-8, 2025. The inspection was conducted to grant or renew registration of BA/BE (Bioavailability/Bioequivalence) study centres. The company confirmed the inspections were completed successfully with only minor observations, and inspectors found the organization compliant with all applicable regulations. Registration renewal/grant for both facilities is expected to be processed in due course.
Positive for shareholders — successful CDSCO compliance means the company's core BA/BE study operations can continue without disruption, supporting ongoing and future business from pharmaceutical clients requiring these regulatory-approved facilities.